Immatics (IMTX) Profit After Tax (2019 - 2025)
Immatics' (IMTX) quarterly Profit After Tax came in at -$39.1 million in Q4 2025, down 198.47% year-on-year from $39.7 million in Q4 2024, and up 33.86% quarter-over-quarter from -$59.1 million in Q3 2025.
Immatics (IMTX) Profit After Tax (2019 - 2025) Analysis & Trends
Immatics has disclosed Profit After Tax across 7 years of filings, most recently posting -$39.1 million for Q4 2025.
- Profit After Tax for Q4 2025 came in at -$39.1 million, down 198.47% year-over-year; the trailing twelve-month figure through Dec 2025 was -$60.5 million (down 217.71% YoY), and the FY2025 annual result was -$221.9 million, down 1464.84% from the prior year.
- Profit After Tax came in at -$39.1 million for Q4 2025 at Immatics, up from -$59.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $96.1 million in Q1 2022 to a low of -$59.1 million in Q3 2025.
- The 5-year median for Profit After Tax is -$12.5 million (2021), against an average of $1.3 million.
- Across the five-year window, Profit After Tax jumped 449.38% in 2022 and plunged 2141.01% in 2025, its largest moves.
- Immatics' Profit After Tax stood at -$19.2 million in 2021, then declined by 22.42% to -$23.5 million in 2022, then fell by 8.94% to -$25.6 million in 2023, then jumped by 254.98% to $39.7 million in 2024, then slumped by 198.47% to -$39.1 million in 2025.
- The last three Profit After Tax figures came in at -$39.1 million (Q4 2025), -$59.1 million (Q3 2025), and $79.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -39.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.08 Mn |
| Sep 30, 2025 | -59.09 Mn |
| Jun 30, 2025 | 79.63 Mn |
| Mar 31, 2025 | -41.92 Mn |
| Dec 31, 2024 | 39.69 Mn |
| Sep 30, 2024 | -5.83 Mn |
| Jun 30, 2024 | 19.38 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Sep 30, 2023 | -28.84 Mn |
| Jun 30, 2023 | 26.80 Mn |
| Mar 31, 2023 | -21.20 Mn |
| Dec 31, 2022 | -23.51 Mn |
| Sep 30, 2022 | -21.11 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 96.14 Mn |
| Dec 31, 2021 | -19.20 Mn |
| Sep 30, 2021 | 32.08 Mn |
| Jun 30, 2021 | 31.95 Mn |
| Mar 31, 2021 | -27.52 Mn |